SCHEMBL613598

SCHEMBL613598

CCCNc1ccc(OC)cc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 7/20 0.79
MAPT P10636 5/20 0.79
ALDH1A1 P00352 2/20 0.61
APP P05067 2/20 0.54
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
L3MBTL1 Q9Y468 2/20 0.54
KDM4E B2RXH2 2/20 0.54
TDP1 Q9NUW8 2/20 0.54
THRB P10828 1/20 0.54
MAPK1 P28482 1/20 0.54
RECQL P46063 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
PPARG P37231 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
MERTK Q12866 1/20 0.49
CHRNA7 P36544 1/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18902087 0.94 GAA (0.70) GAAMAPTALDH1A1APPNPC1
SCHEMBL1030950 0.89 GAA (1.00) GAAMAPTALDH1A1APPNPC1
SCHEMBL2097210 0.88 GAA (0.73) GAAMAPTALDH1A1APPNPC1
SCHEMBL11331749 0.86 GAA (0.70) GAAMAPTALDH1A1APPNPC1
SCHEMBL11338984 0.84 GAA (0.68) GAAMAPTALDH1A1APPNPC1
SCHEMBL11335452 0.84 GAA (0.68) GAAMAPTALDH1A1APPNPC1
SCHEMBL3631474 0.84 GAA (0.68) GAAMAPTALDH1A1APPNPC1
SCHEMBL7001977 0.84 GAA (0.68) GAAMAPTALDH1A1APPNPC1
SCHEMBL11327473 0.84 GAA (0.68) GAAMAPTALDH1A1APPNPC1
SCHEMBL11333048 0.84 GAA (0.68) GAAMAPTALDH1A1APPNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036599-A Dibenzylbutane lignan LCA analogue, and preparation method and application thereof 浙江中医药大学 2026-05-15 CN claimed
CN-117586481-A Method for preparing epoxy resin 浙江大学 2024-02-23 CN claimed
EP-2119363-B1 Enhanced antimicrobial activity of plant essential oils VAN BEEK RONALD R (US) 2019-01-09 EP claimed
CN-122036599-A Dibenzylbutane lignan LCA analogue, and preparation method and application thereof 浙江中医药大学 2026-05-15 CN disclosed
CN-119053326-A Capsaicin derivatives as bioenhancers of active substances metabolized by CYP1A2 and CYP2D6 艾克西化学公司 2024-11-29 CN disclosed
CN-118401830-A Sensor and related systems and methods 麻省理工学院 2024-07-26 CN disclosed
CN-117586481-A Method for preparing epoxy resin 浙江大学 2024-02-23 CN disclosed
EP-3398982-B1 PREPARATION METHOD FOR POLYMER AND APPLICATIONS THEREOF SOBUTE NEW MAT CO LTD (CN) 2023-08-23 EP disclosed
US-20230174462-A1 METHOD FOR THE CONTINUOUS SYNTHESIS OF PARACETAMOL IPSOMEDIC (FR) 2023-06-08 US disclosed
US-10570253-B2 Preparation method for polymer and applications thereof SOBUTE NEW MATERIALS CO., LTD. (CN) 2020-02-25 US disclosed
WO-2019191470-A1 HETEROBICYCLIC INHIBITORS OF MAT2A AND METHODS OF USE FOR TREATING CANCER AGIOS PHARMACEUTICALS, INC. (US) 2019-10-03 WO disclosed
EP-0137145-B1 NEW CAMPTOTHECIN DERIVATIVES AND PROCESS FOR PREPARING SAME KABUSHIKI KAISHA YAKULT HONSHA (JP) 1988-04-27 EP disclosed
US-4604463-A ANTITUMOR AGENTS KABUSHIKI KAISHA YAKULT HONSHA (JP) 1986-08-05 US disclosed
EP-0137145-A1 New camptothecin derivatives and process for preparing same KABUSHIKI KAISHA YAKULT HONSHA (JP) 1985-04-17 EP disclosed
US-4414224-A 4-AMINO OR SUBSTITUTED AMINO-7-HYDROXY-2-(3H)-INDOLONES SMITHKLINE BECKMAN CORPORATION (US) 1983-11-08 US disclosed
EP-0046666-A1 2(3H)-indolones, process for their preparation and compositions containing them SMITHKLINE BECKMAN CORPORATION (US) 1982-03-03 EP disclosed
US-4314944-A CARDIOVASCULAR DISORDERS, HYPOTENSIVE AGENTS SMITHKLINE CORPORATION (US) 1982-02-09 US disclosed
EP-0002721-B1 PROCESS FOR PREPARING HYDRAZINES BAYER AG (DE) 1981-09-02 EP disclosed
EP-0002721-A2 Process for preparing hydrazines BAYER AG (DE) 1979-07-11 EP disclosed
US-4076849-A AROMATIC SECONDARY AMINES CANADA PACKERS LIMITED (CA) 1978-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174462-A1 METHOD FOR THE CONTINUOUS SYNTHESIS OF PARACETAMOL CYP2E1, NANP, GSTP1 GAA 2697/4885MAPT 2312/4885ALDH1A1 293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.